Inaktiver Wert

Trivascular Technologies Inc Aktie

Aktien

Schlusskurs Nasdaq Andere Börsenplätze
- ^USD	-

TriVascular Technologies, Inc. Reports Third Quarter Financial Results	09.11.15
Preliminary Results of the LIFE Study Presented at VIVA 2015	03.11.15
Four-Year Results From Global Ovation Pivotal Trial Presented at VIVA 2015	03.11.15
Trivascular Technologies : Brower Piven Commences An Investigation Into The Proposed Sale Of TriVascular Technologies, Inc. And Encourages Investors To Contact The Firm For Additional Information	29.10.15
TRIVASCULAR TECHNOLOGIES : Former SEC Attorney Willie Briscoe and Powers Taylor LLP Believe the Acquisition by Endologix, Inc. May be Unfair to Shareholders	28.10.15

Manager	Titel	Alter	Seit
John Onopchenko CEO	Chief Executive Officer	66	-
Vaseem Mahboob DFI	Director of Finance/CFO	55	03.02.16

Sektor

	% 1. Jan.	Kap.
STRYKER CORPORATION	+9.96%	127 Mrd.
SMITH & NEPHEW PLC	-6.58%	10.91 Mrd.
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+2.70%	9.24 Mrd.
INSPIRE MEDICAL SYSTEMS, INC.	-19.67%	7.44 Mrd.
GLAUKOS CORPORATION	+34.49%	5.44 Mrd.
AXONICS, INC.	+8.18%	3.44 Mrd.
ENOVIS CORPORATION	-9.55%	2.87 Mrd.
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-5.57%	2.25 Mrd.
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-0.60%	2.23 Mrd.